LMRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lumexa Imaging Holdings Inc (LMRI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown some financial improvement and has positive analyst ratings, the technical indicators are mixed, and there are no strong trading signals or recent positive news catalysts. Given the investor's preference for long-term investments and the lack of immediate strong buy signals, it is better to hold off on purchasing this stock right now.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 38.571, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 8.879, and resistance is at 10.101. The stock is trading below its pivot level of 9.49, suggesting a bearish trend.
Analysts maintain positive ratings with price targets significantly above the current price. Financials show YoY improvement in revenue, net income, EPS, and gross margin.
Lowered price targets from analysts due to soft Q1 outlook and communication issues. Bearish technical indicators and lack of recent news or trading signals.
In Q4 2025, revenue increased by 7.95% YoY to $267.73M. Net income improved by 14.49% YoY but remains negative at -$28.69M. EPS improved by 46.15% YoY to -0.38. Gross margin increased significantly by 134.18% to 11.1%.
Barclays and Raymond James lowered their price targets but maintained positive ratings (Overweight and Strong Buy). Analysts highlight valuation and growth strategy as positives but note concerns about cash flow and communication issues.
